Two great startups win CHF 20’000 at the second stage of Venture Kick
17.11.2016
Two great projects and their teams recently won the second stage of Venture Kick: hemoTUNE and MaxWell Biosystems from ETH Zurich. They will soon pitch in front of the Venture Kick jury again at the big final, where they might win another CHF 100’000.
 The team of hemoTUNE
|
 |
 Meet MaxWell BioSystems
|
|
hemoTUNE (ETH Zurich): Revolutionizing blood purification (Medtech)
hemoTUNE develops a revolutionary therapeutic blood purification platform. Functionalized magnetic nanoparticles applied in a dialysis-like circuit allow specific removal of disease-related compounds directly from a patient's blood in an efficient and mild way.
MaxWell BioSystems (ETH Zurich): Every cell counts (Biotech)
MaxWell BioSystems provides the most advanced electrophysiology instrumentation for high-throughput cell assays to accelerate drug discovery and advance basic research. Their toolset, consisting of an integrated sensor chip, acquisition hardware and software, can be applied in personalized medicine, e.g. using patient stem cell derived neurons for preclinical drug discovery.